Table 2 |
||
|
Currently authorised ARB-based two-drug SPC antihypertensive therapy in Europe in 2011 [69] |
||
|
ARB |
HCTZ combination |
CCB combination |
|
|
||
|
Telmisartan |
✓ |
✓ |
|
|
||
|
Valsartan |
✓ |
✓ |
|
|
||
|
Olmesartan |
✓ |
✓ |
|
|
||
|
Losartan |
✓ |
|
|
|
||
|
Irbesartan |
✓ |
|
|
|
||
|
Candesartan |
||
|
|
||
|
Eprosartan |
||
|
|
||
|
Azilsartan |
||
|
|
||
|
Abbreviations: ARB = angiotensin II receptor blocker; CCB = calcium channel blocker; HCTZ = hydrochlorothiazide; SPC = single-pill combination |
||
|
Mallat Cardiovascular Diabetology 2012 11:32 doi:10.1186/1475-2840-11-32 |
||
